Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Collection and Storage of Biological Samples From Patients Affected by Uveitis for Immunological and Multi-omic Studies (UVEOMICS)

10. november 2026 opdateret af: Maria Vittoria Cicinelli, IRCCS Ospedale San Raffaele

Uveitis is a group of eye diseases that cause inflammation and may lead to vision loss. The biological processes responsible for these diseases are not fully understood, particularly in rare forms of uveitis.

The purpose of UVEOMICS is to collect and store biological samples and clinical information from adults with infectious or non-infectious uveitis, including rare inflammatory eye diseases known as white dot syndromes. Researchers will study these samples to better understand the causes of eye inflammation and identify biological markers that may help improve diagnosis, monitor disease activity, predict relapses, and guide future treatments.

The study plans to enroll approximately 2,000 adults, including 1,500 patients with uveitis and 500 individuals undergoing cataract surgery who will serve as a comparison group.

Participants may provide blood samples and small samples of fluid from inside the eye (aqueous humor or vitreous fluid), when appropriate. Samples and clinical information may be collected at different stages of the disease and during follow-up visits. Biological samples will be stored for future research and analyzed together with clinical findings and eye imaging results.

This is an observational study. Participation will not change the medical care or treatment participants receive.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Undersøgelsestype

Observationel

Tilmelding (Anslået)

200

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Barn
  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population will include approximately 2,000 adults recruited at the IRCCS Ospedale San Raffaele in Milan, Italy.

Approximately 1,500 participants will be patients diagnosed with infectious or non-infectious uveitis, including rare inflammatory eye diseases known as white dot syndromes. An additional 500 participants will be adults without uveitis undergoing elective cataract surgery, who will serve as a comparison group.

Participants will be recruited consecutively during routine outpatient visits, hospital admissions, and diagnostic or surgical procedures. Patients with uveitis may provide biological samples at different stages of their disease, including active inflammation, remission, and relapse.

Recruitment will be non-probabilistic and will include eligible adults regardless of sex or ethnicity who provide written informed consent.

Beskrivelse

Inclusion Criteria:

For patients with uveitis:

Age 18 years or older.

Clinical diagnosis of infectious or non-infectious uveitis (anterior, intermediate, posterior, or panuveitis), including rare white dot syndromes such as multiple evanescent white dot syndrome (MEWDS), punctate inner choroidopathy (PIC), idiopathic multifocal choroiditis (iMFC), acute zonal occult outer retinopathy (AZOOR), acute posterior multifocal placoid pigment epitheliopathy (APMPPE), and serpiginoid chorioretinitis.

Ability to understand and provide written informed consent.

Willingness to provide biological samples (blood and/or aqueous humor and/or vitreous humor, when clinically indicated) and associated clinical information.

Exclusion Criteria:

Age younger than 18 years.

Severe systemic conditions that make biological sample collection unsafe, such as uncontrolled diabetes, systemic infections, or inability to be seated at the slit lamp.

Inability to provide valid informed consent.

Refusal to participate or withdrawal of informed consent.

Pregnancy or breastfeeding if these conditions contraindicate the planned biological sampling.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
uveitis patients

uveitis patients

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of biological samples collected and stored in the UVEOMICS biobank
Tidsramme: Throughout the study period (approximately 6 years).

The total number of biological samples (blood, aqueous humor, and vitreous humor, when clinically available) collected, processed, and stored from enrolled participants for future immunological and molecular research. Samples will be linked to clinical and imaging data and may be collected at different stages of disease activity.

Throughout the study period (approximately 6 years).

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

30. november 2026

Primær færdiggørelse (Anslået)

30. november 2030

Studieafslutning (Anslået)

30. november 2030

Datoer for studieregistrering

Først indsendt

10. november 2026

Først indsendt, der opfyldte QC-kriterier

10. november 2026

Først opslået (Faktiske)

16. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • UVEOMICS
  • UVEOMICS (Anden identifikator: IRCCS SAN RAFFAELE)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .